BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Phalanx Biotech Group Launches Rat Whole Genome OneArray(R)


3/17/2011 7:00:09 AM

BELMONT, Calif., March 16, 2011 /PRNewswire/ -- Phalanx Biotech Group, a global provider of genomic analysis services, announces its newest expression microarray the Rat Whole Genome OneArray®. Curated from RefSeq.42 and Ensemble.59 databases, the Rat OneArray® is comprised of 25,338 long-oligonucleotide probes engineered to meet specific isothermal requirements for superb hybridization performance. This microarray features data reproducibility with CV<4% and demonstrates high correlation with qPCR. The Rat OneArray® provides the most current coverage against the latest rat gene annotations as compared to other commercially available arrays - offering excellent interrogation power into pathways observed in rat disease models and ADMET/DMPK studies.

"Amidst an environment of budget constraints, the release of our high-quality and affordable rat microarray is timely for the rat model research community particularly with increased efforts toward understanding the underlying mechanisms of neurological and inflammatory diseases," said Lester Lien, President, US Operations. "Furthermore, as the FDA starts requiring toxicogenomic data in new drug applications, expression profiling in rat models will be necessary for biomarker development and validation in the drug development process."

The OneArray® product line consists of microarrays for whole genome gene expression available in Human, Mouse, Rat and Yeast, as well as microRNA profiling in all miRBase species. Each array conforms to the strictest quality control standards and is manufactured using proprietary PhalanxJet spotting technology, specialized coating chemistry, and a fully automated assembly system. Phalanx Biotech's unparalleled expertise in microarray technologies forms the basis for an exceptional OneArray® Service Team dedicated to offering genomic research solutions from sample preparation to data interpretation. Leveraging a high-throughput manufacturing facility and streamlined service center, Phalanx offers a continuum of affordable products and services addressing the profiling needs of scientists in areas ranging from discovery research to toxicogenomic testing.

About Phalanx Biotech Group

Phalanx Biotech Group, with operations in California and Taiwan, provides genomics research products and services worldwide to academic, pharmaceutical and biotech communities. Built on world-class, integrated-chip foundry technology, Phalanx Biotech has developed the OneArray® line of high-quality and affordable microarrays for expression profiling of whole genomes, miRNA, and custom targets. Our highly-trained service specialists provide a comprehensive offering of gene expression and miRNA profiling services for biomarker discovery including sample preparation, expression analysis, and qPCR validation. For more information about our products and services, please visit our website at www.phalanxbiotech.com

CONTACT: Audrey Fisher, +1-650-320-8669, afisher@onearray.com

SOURCE Phalanx Biotech Group



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES